Seminar Series | Boston
Building momentum
in mRNA
From discovery through clinical trials
Seminar Series | Boston
Building momentum
in mRNA
From discovery through clinical trials
Seminar highlights | Boston
When
June 11, 2024
2 p.m. - 5 p.m.
Networking hour after the seminar with refreshments
Where
Fee: No Cost.
Limited Seats.
Register below.
Agenda
Nucleoside modification of self-amplifying RNA suppresses the early interferon response and enhances vaccine potency
Joshua McGee
PhD Candidate (Biomedical Engineering), Boston University
Journey through the world of RNA vaccines and therapeutics | Explore saRNA, CRISPR, and modified nucleotides
Stephanie Ramos, PhD
Vice President of R&D Biology, TriLink Biotechnologies
Getting started with mRNA–Increasing your probability for success
Jordana Henderson
Associate Director Technical Design, TriLink Biotechnologies
Questions?
Email us at hello@contentameetings.com
TriLink BioTechnologies does not sell or distribute your information to third parties. For more information, please refer to our Privacy Policy